Follow-up evaluation of women with abnormal cytopathological tests in the municipality of Coari according to the procedures recommended by the ministry of health
DOI:
https://doi.org/10.33159/25959484.repen.2020v31a6Keywords:
Neoplasms, Uterine Cervical Neoplasms, Cytopathological TestsAbstract
Objective: To assess the follow-up of women with abnormal cytopathological tests, according to the procedures recommended by the Ministry of Health. Methods: A cross-sectional, retrospective and descriptive study, carried out at the Women´s Health Care Coordination of the Municipal Health Secretariat of Coari, through the analysis of abnormal cytopathological tests records from January 2015 to December 2016. Results: As regards procedures concerning the 535 abnormal tests found, it was found that the majority of women (58.3%) did not have procedure conduct records registered in the system. Of the 366 women who should return in 6 months, only 126 (23,6%) performed the follow-up cytology in the determined time. Between the 169 patients who should have performed colposcopy and biopsy, 80 performed only colposcopy and only 4 performed colposcopy followed by biopsy according to the recommended procedures. Conclusion: It was found that the majority of women with abnormal tests were not submitted to the procedures recommended by the MH.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018;68(6):394–424. Available at: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21492 DOI: https://doi.org/10.3322/caac.21492
Jardim A, Carlos L, Ferreira DL, Balbinotto G. Cost-effectiveness of the vaccine against human papillomavirus in the Brazilian Amazon region. Rev Assoc Med Bras [Internet]. 2013;9(5):442–51. Available at: https://www.scielo.br/pdf/ramb/v59n5/v59n5a09.pdf DOI: https://doi.org/10.1016/S2255-4823(13)70503-4
Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, et al. Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front Public Heal [Internet]. 2018;6(77):1–12. Available at: http://journal.frontiersin.org/article/10.3389/fpubh.2018.00077/full DOI: https://doi.org/10.3389/fpubh.2018.00077
De Oliveira Santos M. Estimativa/2020 – Incidência de Câncer no Brasil. Rev Bras Cancerol [Internet]. 159o ed 2020;66(1):117. Available at: https://rbc.inca.gov.br/site/arquivos/n_55/v03/pdf/17_artigo2.pdf DOI: https://doi.org/10.32635/2176-9745.RBC.2020v66n1.927
Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes brasileiras para o rastreamento do câncer de colo do útero [Internet]. 2a. Vol. 3. Rio de Janeiro; 2016. p. 31–9. Available at: https://www.inca.gov.br/publicacoes/livros/diretrizes-brasileiras-para-o-rastreamento-do-cancer-do-colo-do-utero
Glick SB, Clarke AR, Blanchard A, Whitaker AK. Cervical cancer screening, diagnosis and treatment interventions for racial and ethnic minorities: A systematic review [Internet]. Vol. 27, Journal of General Internal Medicine. 2012. p. 1016–32. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403140/ DOI: https://doi.org/10.1007/s11606-012-2052-2
Bosch FX, Schiffman M, Solomon D. Introduction: Future Research Directions in the Epidemiology of Human Papillomavirus and Cancer. JNCI Monogr [Internet]. 2003;2003(31):1–2. Available at: https://academic.oup.com/jncimono/article/2003/31/1/951053 DOI: https://doi.org/10.1093/oxfordjournals.jncimonographs.a003470
Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association [Internet]. Vol. 25, Reviews in Medical Virology. 2015. p. 2–23. Available at: https://pubmed.ncbi.nlm.nih.gov/25752814/ DOI: https://doi.org/10.1002/rmv.1822
Heard I, Tondeur L, Arowas L, Falguières M, Demazoin MC, Favre M. Human papillomavirus types distribution in organised cervical cancer screening in France. PLoS One [Internet]. 2013;8(11):1–7. Available at: https://pubmed.ncbi.nlm.nih.gov/24244490/ DOI: https://doi.org/10.1371/journal.pone.0079372
Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine [Internet]. 21 de agosto de 2006 [citado 29 de outubro de 2018];24:S1–10. Available at: https://www.sciencedirect.com/science/article/pii/S0264410X06005913?via%253Dihub DOI: https://doi.org/10.1016/j.vaccine.2006.05.115
Zhen S, Hu CM, Bian LH. Glutathione S-transferase polymorphism interactions with smoking status and HPV infection in cervical cancer risk: An evidence-based meta-analysis. PLoS One [Internet]. 2013;8(12):1–9. Available at: https://pubmed.ncbi.nlm.nih.gov/24391774/ DOI: https://doi.org/10.1371/journal.pone.0083497
Derchain SFM, Longatto Filho A, Syrjanen KJ. Neoplasia intra-epitelial cervical: diagnóstico e tratamento. Rev Bras Ginecol e Obs [Internet]. 2005;27(7):425–33. Available at: https://www.scielo.br/pdf/rbgo/v27n7/a10v27n7.pdf DOI: https://doi.org/10.1590/S0100-72032005000700010
Tota JE, Ramana-Kumar A V., El-Khatib Z, Franco EL. The road ahead for cervical cancer prevention and control [Internet]. Vol. 21, Current Oncology. 2014. p. 255–64. Available at: https://pubmed.ncbi.nlm.nih.gov/24764711/ DOI: https://doi.org/10.3747/co.21.1720
Machado CV, Lima LD de, Viana L da S. Configuração da atenção básica e do Programa Saúde da Família em grandes municípios do Rio de Janeiro, Brasil TT - Organization of traditional Primary Health Care and the Family Health Program in large cities in Rio de Janeiro State, Brazil. Cad Saude Publica [Internet]. 2008;24(supl.1):s42–57. Available at: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0102-311X2008001300010 DOI: https://doi.org/10.1590/S0102-311X2008001300010
Murata IMH, Gabrielloni MC, Schirmer J. Coleta do papanicolau em mulheres de 25 a 59 anos de Maringá-PR,Brasil. Rev Bras Cancerol [Internet]. 2012;58(3):409–15. Available at: http://www1.inca.gov.br/rbc/n_58/v03/pdf/10_artigo_cobertura_papanicolau_mulheres_25_59_anos_maring?_pr_brasil.pdf DOI: https://doi.org/10.32635/2176-9745.RBC.2012v58n3.593
Zardo GP, Farah FP, Mendes FG, Franco CAG dos S, Molina GVM, de Melo GN, et al. Vacina como agente de imunização contra o HPV [Internet]. Vol. 19, Ciencia e Saude Coletiva. 2014. p. 3799–808. Available at: https://www.scielo.br/pdf/csc/v19n9/1413-8123-csc-19-09-3799.pdf DOI: https://doi.org/10.1590/1413-81232014199.01532013
Fonseca AJ, Taeko D, Chaves TA, Da Costa Amorim LD, Murari RSW, Miranda AE, et al. HPV infection and cervical screening in socially isolated indigenous women inhabitants of the amazonian rainforest. PLoS One [Internet]. 2015;10(7): 1–18. Available at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0133635 DOI: https://doi.org/10.1371/journal.pone.0133635
Rocha DAP, Barbosa Filho RAA, De Queiroz FA, Dos Santos CMB. High prevalence and genotypic diversity of the human papillomavirus in amazonian women, Brazil. Infect Dis Obstet Gynecol [Internet]. 2013;1–6. Available at: http://downloads.hindawi.com/journals/idog/2013/514859.pdf DOI: https://doi.org/10.1155/2013/514859
INCA (Brasil). Ministério da Saúde/Instituto Nacional de Câncer José Alencar Gomes da Silva. Laudos Citopatológicos Cervicais Nomenclatura Brasileira para Laudos Citopatológicos Cervicais [Internet]. 3o ed. Ministério da Saúde Instituto Nacional de Cancer José Alencar Gomes da Silva (INCA). Rio de Janeiro; 2012. 1–25 p. Available at: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//nomenclatura-brasileira-para-laudos-citopatologicos-cervicais-2012.pdf
Dalmolin SP, Dexheimer GM, Delving LK de OB. Mulheres com exames citopatológicos alterados: Avaliação do seguimento de acordo com as condutas preconizadas pelo Ministério da Saúde. RBAC [Internet]. 2016;48(3):235–9. Available at: http://sbac.org.br/rbac/wp-content/uploads/2016/11/ARTIGO-8_RBAC-48-3-2016-ref.-444.pdf
Araújo ES, Tavares SB do N, Ázara CZS, Barbosa FM, Ferreira TXAM, Amaral RG. Avaliação do seguimento de mulheres com exames citopatológicosalterados de acordo com as condutas preconizadas pelo Ministério da Saúde do Brasil em Goiânia, Goiás. Rev bras
cancerol [Internet]. 2014;60(1):7–13. Available at: http://www.inca.gov.br/rbc/n_60/v01/pdf/03-artigo-avaliacao-do-seguimento-de-mulheres-com-exames-citopatologicos-alterados-de-acordo-com-as-condutas-preconizadas-pelo-ministerio-da-saude-do-brasil-em-goiania-goias.pdf DOI: https://doi.org/10.32635/2176-9745.RBC.2014v60n1.486
Rodrigues DA, Pereira ÉR, Oliveira LS de S, Speck NM de G, Gimeno SGA. Prevalência de atipias citológicas e infecção pelo papilomavírus humano de alto risco em mulheres indígenas Panará, povo indígena do Brasil Central. Cad Saude Publica [Internet]. 2014;30(12):2587–93. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26247988 DOI: https://doi.org/10.1590/0102-311x00152713
Galão AO, Ramos-lima LF, Vettorazzi J, Mattos JC De, Naud P. Prevalência e seguimento de exame citopatológico de colo uterino com atipias em células escamosas de origem indeterminada em um hospital universitário brasileiro. Rev HCPA [Internet]. 2012;32(3):296–302. Available at: https://seer.ufrgs.br/hcpa/article/view/30389
Rodrigues DA, Pereira ÉR, Oliveira LS de S, Speck NM de G, Gimeno SGA. Prevalence of cytological atypia and high-risk human papillomavirus infection in Panará indigenous women in Central Brazil. Cad Saude Publica. 2014;
Souza JHK de, Kalil IV, Leite JM, Geber S. Avaliação de lâminas de colpocitologia oncótica previamente diagnosticadas como ASCUS: comparação interensaio e interobservadores. Rev Bras Ginecol e Obs [Internet]. 2004;26(3):233–40. Available at: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032004000300010 DOI: https://doi.org/10.1590/S0100-72032004000300010
Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): A community-based randomised controlled trial. Lancet [Internet]. 2011;378(9806):1868–73. Available at: http://dx.doi.org/10.1016/S0140-6736(11)61522-5 DOI: https://doi.org/10.1016/S0140-6736(11)61522-5
Fonseca AJ da, Murari RSW, Moraes IS, Rocha RF, Ferreira LC de L. Acurácia dos exames citológicos cervicovaginais em Estado de elevada incidência de câncer de colo de útero. Rev Bras Ginecol e Obs [Internet]. 2014;36(8):347–52. Available at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032014000800347&lng=pt&nrm=iso&tlng=en DOI: https://doi.org/10.1590/SO100-720320140005061
Zeferino LC. The challenge of reducing mortality due to cervical cancer. Rev Bras Ginecol e Obstet [Internet]. 2008;30(5):213–5. Available at: https://www.researchgate.net/publication/23785977_The_challenge_of_reducing_mortality_due_to_cervical_cancer
Bortolon P. Avaliação da Qualidade dos Laboratórios de Citopatologia do Colo do Útero no Brasil Quality Evaluation of Cervical Cytopathology Laboratories in Brazil. Rev Bras Cancerol [Internet]. 2012;58(3):435–44. Available at: https://rbc.inca.gov.br/revista/index.php/revista/article/view/600/369 DOI: https://doi.org/10.32635/2176-9745.RBC.2012v58n3.600
Maia MN, Silva RP de O da, Santos LPR dos. A organização do rastreamento do câncer do colo uterino por uma equipe de Saúde da Família no Rio de Janeiro, Brasil. Rev Bras Med Família e Comunidade [Internet]. 2018;13(40):1–10. Available at: https://rbmfc.org.br/rbmfc/article/view/1633/911 DOI: https://doi.org/10.5712/rbmfc13(40)1633
Rejane M, Barcelos B, Marechal A, De R, Duarte C, Ii L, et al. Quality of cervical cancer screening in Brazil: external assessment of the PMAQ. [citado 28 de julho de 2020]; Available at: http://www.rsp.fsp.usp.br/
Santos RDS, Caetano E, Melo P, Santos KM. SPATIAL ANALYSIS OF THE INDICATORS AGREED FOR SCREENING CERVIX CANCER IN BRAZIL. Text Context Nurs [Internet]. 2012;21(4):800–10. Available at: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072012000400010
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Paulista de Enfermagem
This work is licensed under a Creative Commons Attribution 4.0 International License.
Propriedade intelectual
Todo o conteúdo da REPEn, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY (https://creativecommons.org/licenses/by/4.0/deed.pt_BR).
